Navigation Links
Don't Believe What You Hear on Countdown: Keith Olbermann's Factual Errors
Date:2/17/2009

NEW YORK, Feb. 17 /PRNewswire-USNewswire/ -- The following is from Betsy McCaughey, Ph.D., the author of the recent Bloomberg.com article, "Ruin Your Health With the Obama Stimulus Plan."

I am requesting that MSNBC and Keith Olbermann apologize and issue a correction.

Mr. Olbermann charges that I, Betsy McCaughey, Ph.D. was paid, directly or indirectly, by the pharmaceutical industry, the biotech industry, the Hudson Institute, or Cantel Medical Corp. to write my analysis of the stimulus bill or speak about that issue. All these charges are false.

I have shown all these charges to be false in a previous statement except the new charge regarding my board membership at Cantel Medical Corp. I serve on the board of Cantel Medical Corp. as a patient advocate and infection prevention expert. No one at Cantel Medical has ever asked me about the stimulus bill or requested that I address the issue. I have not discussed the issue with anyone in the company. I urge those who are interested to contact Cantel Medical directly (973-890-7220).

I have purchased no stock in Cantel Medical. Like all board members, I am routinely issued options. The options cited by Keith Olbermann were not issued to me in payment for my work on the stimulus bill. They were issued to all Cantel board members at the same time. They are issued routinely and periodically. Unlike the other board members, I have never exercised any options to purchase stock. I do not use those options to make money. The same is true for other boards on which I have served.

Sincerely,

Betsy McCaughey, Ph.D.


'/>"/>
SOURCE Betsy McCaughey
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Interleukin Genetics to Present at the 13th International Conference on Periodontal Research
2. Ondine Announces Presentation of Positive Clinical Trial Results at the American Academy of Periodontologys 94th Annual Meeting
3. Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
4. Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit
5. Affitech Appoints Dr. Keith McCullagh as Chairman
6. Surface Logix Appoints Keith Dionne as President and Chief Executive Officer
7. New Wireless ID Skin Patch Technology Designed to Reduce Medical Errors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Research and Markets ( ... "Global & USA BioSimilar Market Analysis to 2021" ... US Biosimilar market will be initiated in September as ... will the global market react? Will biosimilars explode into ... save the US economy up to $250 billion within ...
(Date:8/28/2015)... 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: ... focused on the development of autologous cell therapies, ... June 30, 2015, corporate highlights, and near-term milestones.  ... available at www.sedar.com ,  www.edgar.com ... "RepliCel expects to launch its RCS-01 treatment for ...
(Date:8/27/2015)... ... , ... Capital Edge Consulting , a nationwide consulting firm that specializes ... ranking as one of the top 5000 companies listed on the 2015 Inc. ... , “It is truly an honor to be recognized as one of America’s fastest ...
(Date:8/27/2015)... , Aug. 27, 2015  Asterias Biotherapeutics, Inc. (NYSE ... field of regenerative medicine, today announced that executives from ... the month of September.  , ... Rodman & Renshaw,s 17th Annual Global Investment Conference on ... the St. Regis Hotel in New York ...
Breaking Biology Technology:Global & USA BioSimilar Market Analysis Report 2015-2021 2Global & USA BioSimilar Market Analysis Report 2015-2021 3RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 2Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 3Asterias Biotherapeutics to Present at Upcoming Investor Conferences 2
... settled in for the,winter months and since the common ... days of school and work, now is the time ... Immunity Enhanced Beverage is designed,to do just that. , ... Products, Immunity Enhanced,Beverage is a ready-to-drink liquid supplement intended ...
... Turbulent EconomyOAKBROOK TERRACE, Ill., Jan. 7 AeA, the ... the high-tech industry, announced today that the NASDAQ OMX ... outperformed the Dow Jones Industrial Average (.INDU), S&P 500, ... 2008.On May 19, 2008, AeA and The NASDAQ Stock ...
... YORK, Jan. 7 Aisling Capital announced today that ... newest life sciences fund, Aisling Capital III, LP. Aisling ... developing pharmaceutical, biopharmaceutical and medical products, as well as ... important services to the healthcare industry. With a total ...
Cached Biology Technology:Innovative Beverage Products Launches New Product Designed to Enhance the Body's Immune Defense 2NASDAQ OMX AeA Illinois Tech Index Outperforms Market 2NASDAQ OMX AeA Illinois Tech Index Outperforms Market 3Aisling Capital Announces Close of US$650M Life Sciences Fund 2
(Date:8/12/2015)... , Aug. 12, 2015  New research unveiled ... attack Android phones to steal users, fingerprints. Information ... availability of fingerprint scanners on mobile devices, making ... To secure biometrics on mobile devices, HYPR Corp. ... these convenient authentication systems with strong cryptographic security. ...
(Date:8/10/2015)... and TELTOW, Germany , August 10, ... (SMI), a world leader in Eye Tracking Technology for ... its OEM Eye Tracking Platform for integration into all ... contains reference designs for seamless integration of eye tracking ... reality HMDs and augmented reality smart glasses. Omnivision,s leading ...
(Date:8/6/2015)... Germany , August 6, 2015 ... (SMI) shows the world,s first Eye Tracking ... Epson,s Moverio BT-200 see-through head mounted display and on ... unprecedented quality and efficiency is brought to personalized visualization ... the first time, professionals and researchers can integrate gaze, ...
Breaking Biology News(10 mins):HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3
... - Researchers from the University of Pennsylvania and ... $14.6 million contract from the National Institute of Allergy ... of Health, to expand and extend work on the ... This revolutionary open database enables scientists to examine genes, ...
... us like sport in the physical education classes we ... education teaching staff must develop the responsibility, encourage social ... objective is to make us feel capable of doing ... The objective of the study recently published ...
... (December 10, 2009) Pathological gambling can be ... increase inhibitions, according to researchers at the annual ... Researchers found positive outcomes in gamblers treated ... People with pathological gambling disorder will ...
Cached Biology News:Penn, Georgia collaboration awarded $14.6 million to expand pathogen database 2Penn, Georgia collaboration awarded $14.6 million to expand pathogen database 3Physical education teaching staff play key role in making you like sport 2Pathological gambling may be successfully treated with medications for substance addiction 2
...
2ndGen Predilute antibody for staining tissue sections. Optimized for use with Zymeds Histostain-PLUS, NBA, HistoST5050, and Cap-Plus IHC Kits.Labeling: ASR...
... degradation of single-stranded DNA and RNA endonucleolytically ... nuclease prefers ssDNA over dsDNA by 30,000-fold, ... double-stranded DNA from both ends (1,2). Mung ... mapping studies (3,4), for flushing staggered ends ...
Endomorphin-2. Cross reactivity: Endomorphin-1 3%, Met-enkephalin <0.03%, Leu-enkephalin <0.01% and beta-Endorphin <0.01%....
Biology Products: